tiprankstipranks
Advertisement
Advertisement

Theseus Pharmaceuticals drops 71% after discontinuing THE-630 development

In after-hours trading, shares are down 71% to $2.74.

Claim 30% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on THRX:

Disclaimer & DisclosureReport an Issue

1